ISRCTN73028481CompletedNot Applicable
Preventive Angioplasty in Myocardial Infarction Trial: a randomised controlled trial
Queen Mary University of London (UK)0 sites600 target enrollmentStarted: October 7, 2009Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 600
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Patients (no age limits, either sex) with acute myocardial infarction undergoing a therapeutic angioplasty to the infarct related artery
Exclusion Criteria
- •1. Cardiogenic shock
- •2. Coronary artery bypass graft (CABG)
Investigators
Similar Trials
Recruiting
Not Applicable
The Preventive Coronary Intervention on Stenosis With Functionally Insignificant Vulnerable PlaqueKCT0002893Asan Medical Center1,600
Completed
Not Applicable
Prevention of another myocardial infarction.Heart diseaseCirculatory SystemISRCTN53248571Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Completed
Phase 2
Primary Angioplasty for Acute Myocardial Infarction in Patients With Symptom Duration Above 12 HoursAcute Myocardial InfarctionNCT00260416Aarhus University Hospital Skejby60
Completed
Not Applicable
Myocardial ischemia treated with PCI and coronary plaque regression induced by lipid lowering and blood pressure controlling assessed by intravascular ultrasonographyPatients with coronary artery disease accompanied with hypertension and hypercholesterolemia treated with percutaneous coronary interventionJPRN-UMIN000002829Kanazawa University Graduate School of Medicine, Division of Cardiovascular Medicine100
Active, not recruiting
Not Applicable
Acute STEMI treated with primary angioplasty and intravenous enoxaparin orUFH to lower ischemic and bleeding events at short- and long-term follow-up. - ATOEUCTR2007-007676-42-DEASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)910